Study uncovers antiviral impacts of curcumin Kumar Jeetendra | July 19, 2020 Curcumin, a natural compound found in the spice turmeric, could help remove specific viruses, studies have found. A study published in the Journal of General Virology revealed that curcumin can prevent Transmissible gastroenteritis virus (TGEV) – an alpha-group coronavirus that infects pigs – from infecting cells. At higher doses, the compound was also found to …
Test mRNA-based COVID-19 immunization evokes defensive safe reactions in animals Kumar Jeetendra | July 25, 2020 Two injections of this vaccine were enough to induce robust immunity, completely preventing SARS-CoV-2 infection in mice. MRNA-based vaccines are all attractive options for protecting against SARS-CoV-2 because they may be quickly designed and manufactured at a huge scale within weeks. Moreover, preclinical studies have shown that mRNA-based vaccines cause potent and broadly protective immune …
Protein delivered by the human safe framework can emphatically hinder Sars-Cov-2 Kumar Jeetendra | August 3, 2020 A protein produced by the human immune system may strongly inhibit corona viruses, including Sars-Cov-2, the pathogen causing Covid-19. An international team from Germany, Switzerland and the USA successfully showed the LY6E-Protein prevents coronaviruses from causing the illness. “This finding may result in the development of new therapeutic approaches against coronaviruses,” says Professor Stephanie Pfänder …
Key China COVID-19 examination delivered results that affected ensuing exploration on Covid Kumar Jeetendra | September 18, 2020 Crucial China COVID-19 study produced results that Affected subsequent research on coronavirus Early in the start of the COVID-19 pandemic, a small study in China produced results that affected subsequent research on the virus. Researchers at the University of Cincinnati used the same research parameters on a much larger patient population and reached completely different …
Bruker presents Vutara™ VXL tbest-in-class super-resolution magnifying lens and spatial science investigation abilities Kumar Jeetendra | October 23, 2020 Vutara VXL serves as a biological microscopy workstation for research on DNA, RNA and proteins, from macromolecular complexes and super-structures, to chromatin structure and chromosomal substructures, to studying functional connections in genomes and in various subcellular organelles. This novel system supports innovative spatial biology research in extracellular matrix structures, extracellular vesicles (EV), virology, neuroscience, and …
CRISPR-based test could give fast, affordable testing to help control COVID-19 spread Kumar Jeetendra | December 7, 2020 Imagine swabbing your nostrils, putting the swab in a device, and obtaining a read-out on your mobile phone in 15 to 30 minutes which tells you if you’re infected with the COVID-19 virus. This has been the vision for a group of scientists at Gladstone Institutes, University of California, Berkeley (UC Berkeley), and University of …
New consortium aims to comprehend principles underlying the formation of coronaviruses Kumar Jeetendra | December 10, 2020 “This consortium will aim to comprehend the physical principles underlying the formation of coronaviruses,” said Roya Zandi, a professor of physics and astronomy at UC Riverside and the principal investigator of this four-year project that received funding of over $1.75 million. “We will also explore the effect of some drugs on the assembly process.” Zandi …
IGC analysts get three out of six European Research Council grants Kumar Jeetendra | December 11, 2020 Since the establishment of the European Research Council in 2008, the IGC has secured 17 of the competitive grants (7 Beginning, 8 Consolidator and two Advanced). In 2021, with the beginning of the new grants awarded this month, it will have ten active grants. The year of 2020 marks a total of 327 researchers chosen …
National consortium to examine the impacts of arising SARS-CoV-2 mutations Kumar Jeetendra | January 16, 2021 The’G2P-UK’ National Virology Consortium will study how mutations in the virus affect key outcomes like how transmissible it is, the seriousness of COVID-19 it causes, and the potency of vaccines and treatments. The Consortium will bring together leading virologists from 10 research institutions. They will work together with the COVID-19 Genomics UK (COG-UK) consortium, which …
